CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 222 enrolled
Drug / intervention
ED, DDimers and phone follow upother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00860106
NCT00860106Phase 4Completed
CompareCT.gov

Study of Predictive Echo Doppler Score and D-dimer Level in Evaluation of the Thromboembolic Event Recurrence After Anticoagulant Treatment Cessation.

University Hospital, Grenoble·interventional·Posted Mar 11, 2009·Updated Oct 12, 2011

In Brief

A Phase 4 clinical trial evaluating ED, DDimers and phone follow up for Previous Vka Treatment and Previous Proximal VTE. Completed, enrolled 222 participants across 16 sites.

Detailed Summary

The purpose of this trial is to perform a prospective multicentric study to determine predictive ED score and D-dimer level in the evaluation of the thromboembolic event recurrence after anticoagulant treatment cessation. The patients are included in the study from the anticoagulant treatment cessation. An ED score and a blood sample are performed at this time and one month later. Then, the patients are followed up by phone for 2 years.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrevious Vka Treatment, Previous Proximal VTE
CountriesFrance
Collaborators--

Timeline

Phase 4CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 11, 2009
Enrollment StartMar 1, 2005
Primary CompletionMay 1, 2010
Study CompletionMay 1, 2011
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 17.3 years ago

Interventions

ED, DDimers and phone follow upother

ED score, DDimers level and phone questionnary